Search
Nuwellis Inc
NUWEAdd to Watchlist
3.150USD
+0.010+0.32%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
8.30MMarket Cap
2.31P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.32%
5 Days
-4.55%
1 Month
+630.86%
6 Months
+74.03%
Year to Date
+81.03%
1 Year
-61.79%
Key Figures
3.150Open
3.400High
181.05KVolume
2.31P/E TTM
LossP/E Dynamic
--Dividend TTM
6.87%Turnover Ratio
3.140Prev. Close
3.050Low
425.78KTurnover
LossP/E Static
3.12P/B
0.00%Div Yield TTM
-272.76%ROA
40.07352wk High
0.81Volume Ratio
-10.62MNet Profit
2.64MShares
1.3622EPS TTM
0.22Beta
-610.42%ROE
0.72852wk Low
11.15%Amplitude
70.08%Gross Margin
8.30MMarket Cap
96.91Reward/Risk
6.49%Risk Rate
TradingKey Stock Score of Nuwellis Inc
Currency: USD Updated: 2026-07-02Key Insights
Nuwellis Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 155 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 11.00.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Nuwellis Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Nuwellis Inc Highlights
StrengthsRisks
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Growing
The company is in a growing phase, with the latest annual income totaling USD 8.27M.
Overvalued
The company’s latest PE is 2.31, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 135.71K shares, increasing 30.29% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 6.48.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
11.000
Target Price
+4890.93%
Upside Space
Nuwellis Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nuwellis Inc Info
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Ticker SymbolNUWE
CompanyNuwellis Inc
CEOErb (John L)
Websitehttps://www.nuwellis.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Nuwellis Inc (NUWE)?
The current price of Nuwellis Inc (NUWE) is 3.15.
What is the symbol of Nuwellis Inc?
The ticker symbol of Nuwellis Inc is NUWE.
What is the 52-week high of Nuwellis Inc?
The 52-week high of Nuwellis Inc is 40.07.
What is the 52-week low of Nuwellis Inc?
The 52-week low of Nuwellis Inc is 0.73.
What is the market capitalization of Nuwellis Inc?
The market capitalization of Nuwellis Inc is 8.30M.
Is Nuwellis Inc (NUWE) currently rated as Buy, Hold, or Sell?
According to analysts, Nuwellis Inc (NUWE) has an overall rating of signal_hold, with a price target of 11.00.
What is the Earnings Per Share (EPS TTM) of Nuwellis Inc (NUWE)?
The Earnings Per Share (EPS TTM) of Nuwellis Inc (NUWE) is -25.38.